Hyperactivity in the Gunn rat model of neonatal jaundice: Age-related attenuation and emergence of gait deficits

Pediatric Research

Volumn 77, Issue 3, 2015, Pages 434-439

  Stanford, John A ^a   Shuler, Jeffrey M ^a   Fowler, Stephen C ^b   Stanford, Kimberly G ^a   Ma, Delin ^a   Bittel, Douglas C ^c   Le Pichon, Jean Baptiste ^c,d,e   Shapiro, Steven M ^c,d,e  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIRUBIN INDUCED NEUROLOGICAL DYSFUNCTION; BODY WEIGHT; FORCE; GAIT; GAIT DISORDER; GUNN RAT; HYPERACTIVITY; LIFESPAN; LOCOMOTION; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; NEWBORN; NEWBORN JAUNDICE; NONHUMAN; PRIORITY JOURNAL; RAT; RUNNING; VELOCITY; YOUNG ADULT; ANIMAL; BLOOD; COMPLICATION; GAIT ATAXIA; HYPERKINESIS; PHYSIOLOGY;

BILIRUBIN;

AGE FACTORS; ANIMALS; BILIRUBIN; GAIT ATAXIA; HYPERKINESIS; JAUNDICE, NEONATAL; LOCOMOTION; MALE; RATS; RATS, GUNN;

EID: 84938508989     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.199     Document Type: Article

References (42)

1. Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage-mechanisms and management approaches. N Engl J Med 2013;369:2021-30.
2. Shapiro SM. Kernicterus. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care of the Jaundiced Neonate. New York: McGraw-Hill, 2012:229-42.
3. Hokkanen L, Launes J, Michelsson K. Adult neurobehavioral outcome of hyperbilirubinemia in full term neonates-a 30 year prospective follow-up study. PeerJ 2014;2:e294.
4. Jangaard KA, Fell DB, Dodds L, Allen AC. Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of >or=325 micromol/L (>or=19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000. Pediatrics 2008;122:119-24.
5. Koziol LF, Budding DE, Chidekel D. Hyperbilirubinemia: subcortical mechanisms of cognitive and behavioral dysfunction. Pediatr Neurol 2013;48:3-13.
6. Tsuchie K, Miyaoka T, Furuya M, et al. Te efects of antipsychotics on behavioral abnormalities of the Gunn rat (unconjugated hyperbilirubine-mia rat), a rat model of schizophrenia. Asian J Psychiatr 2013;6:119-23.
7. Gunn CH. Hereditary acholuric jaundice in a new mutant strain of rats. J Hered 1938;29:137-39.
8. Johnson L, Sarmiento F, Blanc WA, Day R. Kernicterus in rats with an inherited defciency of glucuronyl transferase. AMA J Dis Child 1959;97(pt 1):591-608.
9. Schutta HS, Johnson L. Clinical signs and morphologic abnormalities in Gunn rats treated with sulfadimethoxine. J Pediatr 1969;75:1070-9.
10. Daood MJ, Hoyson M, Watchko JF. Lipid peroxidation is not the primary mechanism of bilirubin-induced neurologic dysfunction in jaundiced Gunn rat pups. Pediatr Res 2012;72:455-9.
11. Johnson L, Garcia ML, Figueroa E, Sarmiento F. Kernicterus in rats lacking glucuronyl transferase. II. Factors which alter bilirubin concentration and frequency of kernicterus. Am J Dis Child 1961;101:322-49.
12. Diamond I, Schmid R. Experimental bilirubin encephalopathy. Te mode of entry of bilirubin-14C into the central nervous system. J Clin Invest 1966;45:678-89.
13. Rose AL, Wisniewski H. Acute bilirubin encephalopathy induced with sulfadimethoxine in Gunn rats. J Neuropathol Exp Neurol 1979;38: 152-64.
14. Shapiro SM, Hecox KE. Development of brainstem auditory evoked potentials in heterozygous and homozygous jaundiced Gunn rats. Brain Res 1988;469:147-57.
15. Butcher RE, Stutz RM, Berry HK. Behavioral abnormalities in rats with neonatal jaundice. Am J Ment Defc 1971;75:755-9.
16. Swenson RM, Jew JY. Learning defcits and brain monoamines in rats with congenital hyperbilirubinemia. Exp Neurol 1982;76:447-56.
17. Schutta HS, Johnson L. Bilirubin encephalopathy in the Gunn rat: a fne structure study of the cerebellar cortex. J Neuropathol Exp Neurol 1967;26:377-96.
18. Jew JY, Sandquist D. CNS changes in hyperbilirubinemia. Functional implications. Arch Neurol 1979;36:149-54.
19. Hebert MA, Gerhardt GA. Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fscher 344 rats. Brain Res 1998;797:42-54.
20. Stanford JA, Gerhardt GA. Age-related changes in striatal function of freely-moving F344 rats. Neurobiol Aging 2001;22:659-69.
21. Stanford JA, Gerhardt GA. Aged F344 rats exhibit altered electrophysi-ological activity in locomotor-unrelated but not locomotor-related striatal neurons. Neurobiol Aging 2004;25:509-15.
22. Hannigan JH Jr, Isaacson RL. Te efects of Org 2766 on the performance of sham, neocortical, and hippocampal-lesioned rats in a food search task. Pharmacol Biochem Behav 1985;23:1019-27.
23. Lipska BK, Jaskiw GE, Weinberger DR. Postpubertal emergence of hyper-responsiveness to stress and to amphetamine afer neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuro-psychopharmacology 1993;9:67-75.
24. Wan RQ, Giovanni A, Kafa SH, Corbett R. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behav Brain Res 1996;78:211-23.
25. Naert A, Gantois I, Laeremans A, et al. Behavioural alterations relevant to developmental brain disorders in mice with neonatally induced ventral hippocampal lesions. Brain Res Bull 2013;94:71-81.
26. Blin O, Ferrandez AM, Serratrice G. Quantitative analysis of gait in Parkinson patients: increased variability of stride length. J Neurol Sci 1990;98: 91-7.
27. Koller WC, Trimble J. Te gait abnormality of Huntington's disease. Neurology 1985;35:1450-4.
28. Goldfarb BJ, Simon SR. Gait patterns in patients with amyotrophic lateral sclerosis. Arch Phys Med Rehabil 1984;65:61-5.
29. Chaniary KD, Baron MS, Rice AC, Wetzel PA, Ramakrishnan V, Shapiro SM. Quantifcation of gait in dystonic Gunn rats. J Neurosci Methods 2009;180:273-7.
30. Graham DL, Hasenstab LL, Kinney L, Kuntz JA. Te efects of litter size on the expressiviity of the jaundice genotype in Gunn rats. Dev Psychobiol 1980;13:55-60.
31. Stobie PE, Hansen CT, Hailey JR, Levine RL. A diference in mortality between two strains of jaundiced rats. Pediatrics 1991;87:88-93.
32. Keino H, Kashiwamata S. Critical period of bilirubin-induced cerebellar hypoplasia in a new Sprague-Dawley strain of jaundiced Gunn rats. Neu-rosci Res 1989;6:209-15.
33. Keino H, Aoki E, Kashiwamata S. Postnatal changes of the number and lobular distribution of acid phosphatase positive and lipid granule-containing cells in the cerebellum of hyperbilirubinemic Gunn rats. Neurosci Res 1986;3:183-95.
34. Molinari M, Petrosini L. Hemicerebellectomy and motor behaviour in rats. III. Kinematics of recovered spontaneous locomotion afer lesions at difer-ent developmental stages. Behav Brain Res 1993;54:43-55.
35. Molinari M, Petrosini L, Gremoli T. Hemicerebellectomy and motor behaviour in rats. II. Efects of cerebellar lesion performed at diferent developmental stages. Exp Brain Res 1990;82:483-92.
36. Gould TJ, Bickford PC. Te efects of aging on cerebellar beta-adrenergic receptor activation and motor learning in female F344 rats. Neurosci Lett 1996;216:53-6.
37. Altabella L, Zoratto F, Adriani W, Canese R. MR imaging-detectable metabolic alterations in attention defcit/hyperactivity disorder: from preclini-cal to clinical studies. AJNR Am J Neuroradiol 2014;35:Suppl 6:S55-63.
38. Castellanos FX, Giedd JN, Marsh WL, et al. Quantitative brain magnetic resonance imaging in attention-defcit hyperactivity disorder. Arch Gen Psychiatry 1996;53:607-16.
39. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
40. Wennberg R P, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006;117:474-85.
41. Schwartz H P, Haberman BE, Ruddy RM. Hyperbilirubinemia: current guidelines and emerging therapies. Pediatr Emerg Care 2011;27: 884-9.
42. Fowler SC, Birkestrand BR, Chen R, et al. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patter ning, stereotypies, and tremor. J Neurosci Methods 2001;107: 107-24.